<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03589261</url>
  </required_header>
  <id_info>
    <org_study_id>PI2018_843_0006</org_study_id>
    <nct_id>NCT03589261</nct_id>
  </id_info>
  <brief_title>Hepatic Blood Flow Changes During Fluid Challenge Assessed by MRI in Volunteers Subjects.</brief_title>
  <acronym>PORTEAU</acronym>
  <official_title>Hepatic Blood Flow Changes During Fluid Challenge Assessed by MRI in Volunteers Subjects: a Prospective Monocentric Study. PORTEAU Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hepatic artery and portal flows are both regulated to assume the whole hepatic blood flow.
      Each counts for respectively 25% and 75%. That so-called &quot;buffer response&quot; assumes that when
      portal flow increases, hepatic artery flow decreases. During fluid challenge in intensive
      care unit, fluid challenge is often administered to improve hepatic perfusion. That
      observation is not demonstrated. The aim of the study is to test buffer response and portal
      flow during fluid challenge.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective monocentric study at Amiens Hospital University. 20 volunteers subjects will be
      include after providing informed consent. Fluid challenge will be performed with 500 ml of
      intra venous NaCl (0.9%). Hepatic blood flow measurement will be performed using MRI.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 6, 2018</start_date>
  <completion_date type="Actual">March 29, 2019</completion_date>
  <primary_completion_date type="Actual">March 29, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Portal blood flow measure before and after fluid challenge</measure>
    <time_frame>Two hours: the difference in hepatic portal flow before and after a volume expansion of 500 ml NaCl 0.9%.</time_frame>
    <description>Fluid challenge will be performed with 500 ml of intra venous NaCl (0.9%). Hepatic blood flow measurement will be performed using MRI (magnetic resonance imaging).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hepatic artery blood flow measure before and after fluid challenge</measure>
    <time_frame>Two hours</time_frame>
    <description>Hepatic artery blood flow measure before and after a volume expansion of 500 ml NaCl 0.9%.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Flow ratio of portal flow on hepatic artery flow</measure>
    <time_frame>Two hours</time_frame>
    <description>Flow ratio of portal flow on hepatic artery flow before and after a volume expansion of 500 ml NaCl 0.9%.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Hepatic Flow Changes</condition>
  <arm_group>
    <arm_group_label>MRI (magnetic resonance imaging)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Hepatic blood flow baseline will be measured using MRI. Fluid challenge of 500 ml of NaCl 0.9% will be administered during 10 minutes. Before and After fluid challenge, MRI will be performed to compare flow changes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI (magnetic resonance imaging)</intervention_name>
    <description>Fluid challenge will be performed with 500 ml of intra venous NaCl (0.9%). Hepatic blood flow measurement will be performed using MRI.</description>
    <arm_group_label>MRI (magnetic resonance imaging)</arm_group_label>
    <other_name>500 ml of intra venous NaCl (0.9%).</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fasting for the last 12 hours.

        Exclusion Criteria:

          -  Claustrophobia

          -  Any previous medical history disease;

          -  Any abdominal surgical disease

          -  Pregnancy or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Amiens-Picardie</name>
      <address>
        <city>Amiens</city>
        <zip>80000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>July 3, 2018</study_first_submitted>
  <study_first_submitted_qc>July 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2018</study_first_posted>
  <last_update_submitted>April 1, 2019</last_update_submitted>
  <last_update_submitted_qc>April 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

